ChemoCentryx, Inc. (CCXI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.36B |
| Enterprise Value | 1.10B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 49.56 |
| Price/Book (mrq) | 5.28 |
| Enterprise Value/Revenue | 40.42 |
| Enterprise Value/EBITDA | -8.18 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.84 |
| 52-Week Change 3 | 93.83% |
| S&P500 52-Week Change 3 | -3.35% |
| 52 Week High 3 | 42.16 |
| 52 Week Low 3 | 9.53 |
| 50-Day Moving Average 3 | 21.84 |
| 200-Day Moving Average 3 | 26.44 |
Share Statistics
| Avg Vol (3 month) 3 | 1.45M |
| Avg Vol (10 day) 3 | 2.69M |
| Shares Outstanding 5 | 71.19M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 58.47M |
| % Held by Insiders 1 | 11.96% |
| % Held by Institutions 1 | 76.20% |
| Shares Short (Apr 28, 2022) 4 | 6M |
| Short Ratio (Apr 28, 2022) 4 | 5.13 |
| Short % of Float (Apr 28, 2022) 4 | 10.45% |
| Short % of Shares Outstanding (Apr 28, 2022) 4 | 8.43% |
| Shares Short (prior month Mar 30, 2022) 4 | 7.22M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2021 |
| Most Recent Quarter (mrq) | Dec 30, 2021 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -403.17% |
Management Effectiveness
| Return on Assets (ttm) | -17.19% |
| Return on Equity (ttm) | -39.23% |
Income Statement
| Revenue (ttm) | 32.22M |
| Revenue Per Share (ttm) | 0.46 |
| Quarterly Revenue Growth (yoy) | -46.90% |
| Gross Profit (ttm) | -51.07M |
| EBITDA | -126.78M |
| Net Income Avi to Common (ttm) | -131.75M |
| Diluted EPS (ttm) | -1.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 264.49M |
| Total Cash Per Share (mrq) | 3.73 |
| Total Debt (mrq) | 73.28M |
| Total Debt/Equity (mrq) | 25.61 |
| Current Ratio (mrq) | 4.27 |
| Book Value Per Share (mrq) | 4.07 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -75.62M |
| Levered Free Cash Flow (ttm) | -70.88M |
